Biotech

All Articles

Lilly- supported weight-loss biotech reports IPO

.After raising $170 million back in February, metabolic disease-focused BioAge Labs has actually fil...

Aelis' cannabis usage medicine fails period 2b, steering Indivior to review $100M alternative

.Aelis Farma's chances of getting a quick, favorable choice on a $one hundred million possibility re...

ProKidney standstills phase 3 test certainly not needed for tissue treatment confirmation

.ProKidney has stopped some of a set of stage 3 trials for its cell treatment for kidney condition a...

Vaxcyte climbs on 'impressive' 31-valent PCV gain against Pfizer

.Vaxcyte revealed what experts called "stunning" phase 1/2 data for its own 31-valent pneumococcal v...

Recursion's human brain condition test reveals scant evidence of efficiency

.Recursion has actually discovered via an early test of its own tech-enabled technique to medicine e...

Acepodia, Pfizer click together for chemistry-based tissue therapy

.Phone it a situation of excellent chemical make up: Acepodia, a biotech based on Nobel Prize-winnin...

Praxis epilepsy medicine decreases seizures in stage 2 trial

.Praxis Accuracy Medicines has scored another midphase gain in epilepsy this year, along with its ow...

Three execs resign as Dyne messages blended data for DMD applicant

.After leaving a professional grip several years back, Dyne Rehab has actually exposed new phase 1/2...

Arrowhead fires off period 3 data in rare metabolic condition before market encounter Ionis

.Arrowhead Pharmaceuticals has actually revealed its own hand in advance of a possible face-off alon...

Pfizer, Valneva reveal lyme illness shot reliable for second enhancer

.Pfizer and Valneva may possess regarding two additional years to wait before they create the very f...